Treatment Choice and Quality of Life in Patients With Choroidal Melanoma

Two-year patient-reported outcomes following treatment of uveal melanoma

“…Nevertheless, those providing data at 2 years were broadly similar to those who withdrew on key clinical and socio-demographic characteristics, and all initial PROMs measures at 6 months. Moreover, retention is within the range of previous studies (40-93%; [5][6][7][8][9][10]12 ). Second, we did not make an assessment of mood disturbance or QoL before treatment because we did not wish to burden patients during this period of acute distress.…”

Two-year patient-reported outcomes following treatment of uveal melanoma

“…Nevertheless, those providing data at 2 years were broadly similar to those who withdrew on key clinical and socio-demographic characteristics, and all initial PROMs measures at 6 months. Moreover, retention is within the range of previous studies (40-93%; [5][6][7][8][9][10]12 ). Second, we did not make an assessment of mood disturbance or QoL before treatment because we did not wish to burden patients during this period of acute distress.…”

Reactions to and Desire for Prognostic Testing in Choroidal Melanoma Patients

“…Because of this, the quality of life of our sample cannot be compared to an analogous group of patients. However, the average mental health ( M = 52.7) and physical health ( M = 44.9) quality of life scores of the total sample mirrored the average scores of an age-matched population sample (i.e., mental health M = 51.05, physical health M = 45.9), as well as those of another uveal melanoma sample reported by Cruickshanks and colleagues (mental health M = 54.8, physical health M = 45.6) with a similar age and gender distribution ( 1999 ). Furthermore, depressive symptoms and quality of life in psychological and physical domains did not differ significantly between patients who received a monosomy 3, disomy 3, or an inconclusive result.…”

Long‐term uveal melanoma survivors: measuring their quality of life

“…These differences were most evident in the analysis of the effect of treatment choice on the QoL. Cruickshanks found no differences between radiation-and enucleationrelated QoL (Cruickshanks et al 1999). The data presented by Chabert and by Klingenstein tell a different story that matches our findings (Chabert et al 2004;Klingenstein et al 2016).…”

Two-year patient-reported outcomes following treatment of uveal melanoma

“…Nevertheless, those providing data at 2 years were broadly similar to those who withdrew on key clinical and socio-demographic characteristics, and all initial PROMs measures at 6 months. Moreover, retention is within the range of previous studies (40-93%; [5][6][7][8][9][10]12 ). Second, we did not make an assessment of mood disturbance or QoL before treatment because we did not wish to burden patients during this period of acute distress.…”

Reactions to and Desire for Prognostic Testing in Choroidal Melanoma Patients

“…Because of this, the quality of life of our sample cannot be compared to an analogous group of patients. However, the average mental health ( M = 52.7) and physical health ( M = 44.9) quality of life scores of the total sample mirrored the average scores of an age-matched population sample (i.e., mental health M = 51.05, physical health M = 45.9), as well as those of another uveal melanoma sample reported by Cruickshanks and colleagues (mental health M = 54.8, physical health M = 45.6) with a similar age and gender distribution ( 1999 ). Furthermore, depressive symptoms and quality of life in psychological and physical domains did not differ significantly between patients who received a monosomy 3, disomy 3, or an inconclusive result.…”

Long‐term uveal melanoma survivors: measuring their quality of life

“…These differences were most evident in the analysis of the effect of treatment choice on the QoL. Cruickshanks found no differences between radiation-and enucleationrelated QoL (Cruickshanks et al 1999). The data presented by Chabert and by Klingenstein tell a different story that matches our findings (Chabert et al 2004;Klingenstein et al 2016).…”

Two-year patient-reported outcomes following treatment of uveal melanoma

“…Nevertheless, those providing data at 2 years were broadly similar to those who withdrew on key clinical and socio-demographic characteristics, and all initial PROMs measures at 6 months. Moreover, retention is within the range of previous studies (40-93%; [5][6][7][8][9][10]12 ). Second, we did not make an assessment of mood disturbance or QoL before treatment because we did not wish to burden patients during this period of acute distress.…”

Reactions to and Desire for Prognostic Testing in Choroidal Melanoma Patients

“…Because of this, the quality of life of our sample cannot be compared to an analogous group of patients. However, the average mental health ( M = 52.7) and physical health ( M = 44.9) quality of life scores of the total sample mirrored the average scores of an age-matched population sample (i.e., mental health M = 51.05, physical health M = 45.9), as well as those of another uveal melanoma sample reported by Cruickshanks and colleagues (mental health M = 54.8, physical health M = 45.6) with a similar age and gender distribution ( 1999 ). Furthermore, depressive symptoms and quality of life in psychological and physical domains did not differ significantly between patients who received a monosomy 3, disomy 3, or an inconclusive result.…”

Long‐term uveal melanoma survivors: measuring their quality of life

“…These differences were most evident in the analysis of the effect of treatment choice on the QoL. Cruickshanks found no differences between radiation-and enucleationrelated QoL (Cruickshanks et al 1999). The data presented by Chabert and by Klingenstein tell a different story that matches our findings (Chabert et al 2004;Klingenstein et al 2016).…”